Feminizing Therapy in People With Klinefelter Syndrome and Gender Incongruence: Considerations for Treatment Without Testosterone Blockers
Andrology · 2026-07-02
DOI: 10.1111/andr.70290 ↗At a glance
Journal article in Andrology, published online on 2026-07-02. Written by Maaike Kroon and 3 co-authors. Institution: Amsterdam UMC location Vrije Universiteit Amsterdam, Center of Expertise on Gender Dysphoria, Amsterdam, The Netherlands. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Klinefelter syndrome (KS; 47, XXY) usually involves male sex development and gender identity. Small studies suggest gender incongruence may be more common in KS, but feminizing gender‑affirming hormone therapy in this group has been scarcely reported.
Objectives
To evaluate current feminizing hormone therapy in individuals with KS and the number of individuals with KS attending our gender clinic. Materials and Methods We conducted a care evaluation of individuals with KS referred to the Center of Expertise on Gender Dysphoria (Amsterdam UMC) between February 1972 and May 2025, collecting data on KS diagnosis, testosterone use, referral age, feminizing hormone therapy, and hormone concentrations.
Results
Eight (0.12%) people had KS. Median age at KS diagnosis was 25.3 years (IQR 16.9–37.5, n = 8), and at gender clinic intake 45.3 years (IQR 34.2–52.2, n = 8). Among estradiol users, median age was 45.7 years (IQR 42.4–57.1, n = 6). None of those retaining their testes use testosterone blockers (follow‑up: median 5.4 years (3.6–7.7), n = 5).
Discussion
In KS, estradiol alone may sufficiently suppress testosterone. KS prevalence in our cohort does not exceed that of the general population.
Conclusion
Given KS‑related hypogonadism, estradiol monotherapy may be an appropriate first‑line feminizing hormone therapy, avoiding routine use of testosterone blockers.
Subjects
Author keywords
Authors and institutions
- Amsterdam UMC location Vrije Universiteit Amsterdam, Center of Expertise on Gender Dysphoria, Amsterdam, The Netherlands.
- Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
- Amsterdam Public Health, Health Behaviors and Chronic Diseases, Amsterdam, The Netherlands.
- Amsterdam UMC location University of Amsterdam, Paediatric Endocrinology, Amsterdam, The Netherlands.
- Amsterdam Reproduction and Development, Amsterdam, The Netherlands.
ORCID profiles: Maaike Kroon
Cite
APA
Kroon, M., Klooker, T. K., Hannema, S. E., & Den Heijer, M. (2026). Feminizing Therapy in People With Klinefelter Syndrome and Gender Incongruence: Considerations for Treatment Without Testosterone Blockers. Andrology. https://doi.org/10.1111/andr.70290
Vancouver
Kroon M, Klooker TK, Hannema SE, Den Heijer M. Feminizing Therapy in People With Klinefelter Syndrome and Gender Incongruence: Considerations for Treatment Without Testosterone Blockers. Andrology. 2026. doi:10.1111/andr.70290
BibTeX
@article{Kroon2026,
author = {Kroon, Maaike and Klooker, Tamira Klaziene and Hannema, Sabine Elisabeth and Den Heijer, Martin},
title = {Feminizing Therapy in People With Klinefelter Syndrome and Gender Incongruence: Considerations for Treatment Without Testosterone Blockers},
journal = {Andrology},
year = {2026},
doi = {10.1111/andr.70290}
}
EUVIMED